Multidrug resistant Psudomonas aeruginosa infections complicating surgical wounds and the potential challenges in managing post-operative wound infections: University of Calabar Teaching Hospital experience

Asian Pacific Journal of Tropical Medicine

Volumn 3, Issue 6, 2010, Pages 479-482

  Jombo, G T ^a   Akpan, S ^b   Epoke, J ^b   Denen, Akaa P ^a   Odey, F ^b  

^a BENUE STATE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF CALABAR   (Nigeria)

Author keywords

Antibiotic susceptibility; Pseudomonas aeruginosa; Surgical site infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFTRIAXONE; COLISTIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; OFLOXACIN; STREPTOMYCIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; EMERGENCY WARD; ENT WARD; FEMALE; GYNECOLOGIC WARD; HUMAN; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MATERNITY WARD; MULTIDRUG RESISTANCE; NONHUMAN; OPHTHALMIC WARD; ORTHOPEDIC WARD; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURGICAL WARD; SURGICAL WOUND; WARD;

EID: 77954025019     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(10)60115-0     Document Type: Article

References (34)

1. Drago L, De Vechi E, Nicola L, Colombo A, Guerra A, Gismondo MR Activity of levofloxacin and ciprofloxacin with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacterp. Chemotherapy 2004, 50:202-210.
2. Andes DR, Craig WA Cephalosporins. Mandell, Douglas and Bennett's principles and practice of infectious diseases 2005, 294-311. Churchill Livingstone, Philadelphia. 6th ed. G.L. Mandell, J.E. Bennet, R. Dolin (Eds.).
3. Talbot GH, Bradley J, Edwards JE, Gilbert D, Scheld M, Bartlett JG Bad bugs need drugs: An update on the Development pipeline from the antimicrobial availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006, 42:657-668.
4. Gladstone P, Rajendran P, Brahmadathan KN Incidence of carbapenem resistant non fermenting gram negative bacilli from patients with respiratory infections in Intensive Care Units. Indian J Med Microbiol 2005, 23:189-191.
5. Maillard JY Bacterial resistance to biocides in the healthcare environment: should it be of genuine concern?. J Hosp Infect 2007, 65(Suppl 2):60-72.
6. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO In Vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumanii isolated from intensive care units. Int J Antimicrob Agents 2006, 27(3):224-228.
7. Masterton RG, Kuti JL, Turner PJ, Nicolau DP The OPTIMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe. J Antimicrob Chemother 2005, 55(1):71-77.
8. Jombo GTA, Jonah P, Ayeni JA Multidrug resistant Pseudomonas aeruginosa in contemporary medical practice: Findings from urinary isolates at a Nigerian University Teaching Hoapital. Nig J Physiological Sci 2008, 23(1&2):105-109.
9. Jombo GTA, Okwori EE, Peters EJ, Umana AN Multi-drug resistant Pseudomonas aeruginosa from ear discharges and potential challenges in treatment of ear infections: Findings from Makurdi, North central Nigeria. Mary Slessor J Med 2008, 8(2):10-16.
10. Erlandsson M, Gill H, Nordlinder D, Giske CG, Jonas D, Nilsson LE, et al. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs. Scand J Infect Dis 2008, 40(6-7):487-494.
11. Tan L, Sun X, Zhu X, Zhang Z, Li J, Shu Q Epidemiology of nosocomial pneumonia in infants after cardiac surgery. Chest 2004, 125(2):410-417.
12. Batura D, Rao GG, Nielson PB Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BUJ Int 2010, PMD 20346055 [Epud Ahead of Print].
13. Ezechi OC, Edet A, Akinlade H, Gab-Okafor CV, Herbertson E Incidence and risk factors for caesarean wound infection in Lagos, Nigeria. BMC Res Notes 2009, 2:186e. http://www.biomedcentral.com/1756-0500/2/186.
14. Thanni LO, Aigoro NO Surgical site infection complicating internal fixation of fractures: incidence and risk factors. J Natl Med Assoc 2004, 96:1070-1072.
15. Tsering DC, Das S, Adhiakari L, Pal R, Singh TS Extended-spectrum beta-lactamase detection in gram negative bacilli of nosocomial origin. J Glob Infect Dis 2009, 1(2):87-92.
16. Wirth FW, Picoli SU, Cantarelli VV, Goncalves AL, Brust FR Santos LM, et al. Metallo-beta-lactamase-producing Pseudomonas aeruginosa in two hospitals from southern Brazil. Braz J Infect Dis 2009, 13(3):170-172.
17. Achudume AC, Olawale JT Occurrence of antibiotic resistant bacteria in waste site of Ede, south west Nigeria. J Environ Biol 2009, 30(2):187-189.
18. Chen WY, Jang TN, Huang CH, Hsueh PR In Vitro susceptibilities of aerobic and facultative anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections at a medical centre in Taiwan: results of the study for monitoring antimicrobial resistance trends (SMART) 2002-2006. J Microbiol Immunol Infect 2009, 42(4):317-323.
19. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. CLSI Document M100-S16 2006, CLSI, Wayne, PA, USA. 16th ed.
20. Forbes BA, Sahm DF, Weissfeld AS Bailey and Scott's diagnostic microbiology 2007, 251-253. Mosby Elsevier, Missouri. 12th ed.
21. Haas JP, Evans AM, Preston KE, Larson EL Risk factors for surgical site infection after cardiac surgery. The role of endogenous flora. Heart Lung 2005, 34:108-114.
22. Oguntibeju OO, Nwobu RAU Occurrence of Pseudomonas aeruginosa in post-operative wound infection. Pak J Med Sci 2004, 20(3):187-191.
23. Olayinka AT, Onile BA, Olayinka BO Prevalence of multidrug resistance (MDR) Pseudomonas aeruginosa isolates in surgical units of Ahmadu Bello University teaching hospital, Zaria, Nigeria: An indication for effective control measures. Ann Afr Med 2004, 3(1):13-16.
24. Jombo GTA, Ayilara AO, Bello K, Gadzama GB, Mbaawuaga EM Microbial isolates from surgical sites infection at a Federal Medical Centre in North Eastern Nigeria. Mary Slessor J Med 2006, 6(2):59-66.
25. Tomozawa T, Sugihara C, Kakuta M, Sugihara K, Koga T In Viteo postantibiotic effects of tomopenem (CS-023) against Staphylococcus aureus and Pseudomonas aeruginosa. J Med Microbiol 2010, 59(4):438-441.
26. Miriagou V, Camagila G, Edelstein M, Galani I, Giske CG, Gniadkowski M, et al. Acquired carbapenemases in Gram negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 2010, 16(2):112-122.
27. Vyhnanet F, Adamkova V, Duchac V, Teplan V, Jirasek T Antimicrobial treatment of nosocomial intra-abdominal infections-new treatment options with tygcycline. Rozhl Chir 2009, 88(9):503-507.
28. Zhang ZQ, Qlan YY, Liu G, Li TS, Meng QY Vicissitude of antibiotic sensitivity of Gram negative bacilli in patients with infection in emergency departments in Beijing during 2005 to 2007. Zhongguo Wei Zhong Ji Jiu Yi Xue 2009, 21(12):738-741.
29. Srinivas N, Jetter P, Ueberbacher BJ, Werneburg M, Zerbe K, Steinmann J, et al. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 2010, 327(5968):1010-1013.
30. Allou N, Kermarrec N, Muller C, Thabut G, Philip I, Lucet JC, Montravers P Risk factors and prognosis of post operative pneumonia due to Pseudomonas aeruginosa following cardiac surgery. J Antimicrob Chemother 2010, 65(4):806-807.
31. Mela EK, Drintzias EG, Christofidou MK, Filos KS, Anastassion ED, Gartaganis SP Ocular surface bacterial colonization in sedative care unit patients. Anaesth Intensive Care 2010, 38(1):190-193.
32. Licker M, Bafdiafoiu L, Negru C, Barnzeu C, Zugravu R, Horhat F, Moldovan R Bacterial multi-resistance emergence in South-Western Romania. Bacteriol Virusol Parazitol Epidemiol 2009, 54(2):79-86.
33. Juan C, Zamorano L, Mena A, Alberti S, Perez JL, Oliver A Metallo-beta-lactamase-producing Pseudomonas putidi as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones. J Antimicrob Chemother 2010, 65(3):474-478.
34. Huang J, Tang YQ, Sun JY Intravenous colistin sulphate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram negative bacterial infections. Scand J Infect Dis 2010, 42(4):260-265.